⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Baroda BNP Paribas Multi Cap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Baroda BNP Paribas | HDFC MF |
| Category | Equity - Multi Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹315.37 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★ | ★★★★★ |
| Benchmark | Nifty500 Multicap 50:25:25 - TRI | BSE Health Care - TRI |
| Fund Manager | Paresh Jain | Nikhil Mathur |
| Inception | 01 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | -3.47% | 22.64% |
| 3Y | 13.80% | 30.41% |
| 5Y | 10.97% | — |
| Since Inception | 14.19% | 29.15% |
| Risk | ||
| 14.88 | 14.07 | |
| 0.96 | 0.59 | |
| 0.51 | 1.59 | |
| 2.43 | 21.67 | |
| 0.93 | 3.48 | |
| -11.52% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.20% | 1.03% |
| Exit Load | 1% on or before 365D, Nil after 365D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹500 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Baroda BNP Pa…96%
HDFC MF96%
3.8%Only 3.8% of holdings by weight are common between Baroda BNP Paribas and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingBaroda BNP ParibasHDFC MF
Acutaas Chemicals Ltd.1.99%3.18%
Torrent Pharmaceuticals Ltd.1.83%3.65%
Category context: Equity vs Equity. Open the full Screener →